These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 1740321)

  • 21. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus.
    Rigoli L; Raimondo G; Di Benedetto A; Romano G; Porcellini A; Campo S; Corica F; Riccardi G; Squadrito G; Cucinotta D
    Acta Diabetol; 1995 Dec; 32(4):251-6. PubMed ID: 8750764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The gene causing familial hypoalphalipoproteinemia is not caused by a defect in the apo AI-CIII-AIV gene cluster in a Spanish family.
    Kastelein JJ; Haines JL; Hayden MR
    Hum Genet; 1990 Apr; 84(5):396-400. PubMed ID: 1969839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haplotype analysis of Apo AI-CIII-AIV gene cluster and lipids level: Tehran Lipid and Glucose Study.
    Daneshpour MS; Faam B; Mansournia MA; Hedayati M; Halalkhor S; Mesbah-Namin SA; Shojaei S; Zarkesh M; Azizi F
    Endocrine; 2012 Feb; 41(1):103-10. PubMed ID: 22105741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A PvuII polymorphism in the 5' flanking region of the apolipoprotein AIV gene: its use to study genetic variation determining serum lipid and apolipoprotein concentration.
    Kessling AM; Taylor R; Temple A; Hutson J; Hidalgo A; Humphries SE
    Hum Genet; 1988 Mar; 78(3):237-9. PubMed ID: 2894347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.
    Dallinga-Thie GM; van Linde-Sibenius Trip M; Rotter JI; Cantor RM; Bu X; Lusis AJ; de Bruin TW
    J Clin Invest; 1997 Mar; 99(5):953-61. PubMed ID: 9062353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apolipoprotein A-I gene polymorphisms: frequency in patients with coronary artery disease and healthy controls and association with serum apo A-I and HDL-cholesterol concentration.
    Wile DB; Barbir M; Gallagher J; Myant NB; Ritchie CD; Thompson GR; Humphries SE
    Atherosclerosis; 1989 Jul; 78(1):9-18. PubMed ID: 2569310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variations in the apolipoprotein AI-CIII-AIV gene region and in lecithin:cholesterol acyltransferase concentration are determinants of plasma cholesterol concentrations.
    Kessling AM; Nanjee MN; Miller NE; Humphries SE
    Atherosclerosis; 1988 Mar; 70(1-2):13-9. PubMed ID: 2895659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronary heart disease, echo-Doppler evidence of peripheral arterial disease and polymorphism of apolipoprotein B gene and Apo AI/CIII cluster.
    De Lorenzo F; Rubba P; Monticelli A; Cocozza S
    Angiology; 1993 Oct; 44(10):785-90. PubMed ID: 8105730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [DNA polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster in coronary artery disease].
    Dan Q; Huang Y; Peng Z
    Zhonghua Yi Xue Za Zhi; 1995 Oct; 75(10):584-7, 637. PubMed ID: 8697070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic linkage of the human apolipoprotein AI-CIII-AIV gene cluster and the neural cell adhesion molecule (NCAM) gene.
    Mietus-Snyder M; Charmley P; Korf B; Ladias JA; Gatti RA; Karathanasis SK
    Genomics; 1990 Aug; 7(4):633-7. PubMed ID: 1974882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status.
    Peacock RE; Temple A; Gudnason V; Rosseneu M; Humphries SE
    Genet Epidemiol; 1997; 14(3):265-82. PubMed ID: 9181356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between MspI polymorphism of the APO AI gene and Type 2 diabetes mellitus.
    Morcillo S; Cardona F; Rojo-Martínez G; Esteva I; Ruíz-de-Adana MS; Tinahones F; Gómez-Zumaquero JM; Soriguer F
    Diabet Med; 2005 Jun; 22(6):782-8. PubMed ID: 15910632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Candidate genes involved in cardiovascular risk factors by a family-based association study on the island of Kosrae, Federated States of Micronesia.
    Han Z; Heath SC; Shmulewitz D; Li W; Auerbach SB; Blundell ML; Lehner T; Ott J; Stoffel M; Friedman JM; Breslow JL
    Am J Med Genet; 2002 Jul; 110(3):234-42. PubMed ID: 12116231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA restriction polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster: a genetic determinant of atherosclerosis in type 2 (non-insulin-dependent) diabetes mellitus.
    Renard E; Dupuy AM; Monnier L; Crastes de Paulet A
    Diabet Med; 1991 May; 8(4):354-60. PubMed ID: 1677323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracoronary atherosclerosis and genetic variants of apolipoprotein AI-CIII cluster in myocardial infarction survivors from southern Italy.
    De Lorenzo F; Monticelli A; Cocozza S; De Simone B; Rubba P
    Clin Investig; 1994 Jun; 72(6):435-41. PubMed ID: 7950154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and sequence analysis of the human apolipoprotein CIII gene and the intergenic region between the apo AI and apo CIII genes.
    Protter AA; Levy-Wilson B; Miller J; Bencen G; White T; Seilhamer JJ
    DNA; 1984 Dec; 3(6):449-56. PubMed ID: 6439535
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of a DNA polymorphism of the apolipoprotein AI-CIII-AIV gene cluster with myocardial infarction in a Tunisian population.
    Sediri Y; Kallel A; Feki M; Mourali S; Elasmi M; Abdessalem S; Mechmeche R; Jemaa R; Kaabachi N
    Eur J Intern Med; 2011 Aug; 22(4):407-11. PubMed ID: 21767760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three new polymorphisms of the ApoAI-CIII-AIV gene cluster.
    Xu CF; Talmud P; Humphries S
    Mol Cell Probes; 1994 Aug; 8(4):331-2. PubMed ID: 7870077
    [No Abstract]   [Full Text] [Related]  

  • 39. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: correlation of plasma APOCIII with triglyceride level and body mass index.
    Wu JH; Kao JT; Wen MS; Lo SK
    J Formos Med Assoc; 2000 May; 99(5):367-74. PubMed ID: 10870325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia.
    Groenendijk M; Cantor RM; Blom NH; Rotter JI; de Bruin TW; Dallinga-Thie GM
    J Lipid Res; 1999 Jun; 40(6):1036-44. PubMed ID: 10357835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.